These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 33084522)
1. MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer. Shayimu P; Yusufu A; Rehemutula A; Redati D; Jiapaer R; Tuerdi R Technol Cancer Res Treat; 2020; 19():1533033820967475. PubMed ID: 33084522 [TBL] [Abstract][Full Text] [Related]
2. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2. Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759 [TBL] [Abstract][Full Text] [Related]
3. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
4. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Ji H; Sang M; Liu F; Ai N; Geng C Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer. Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211 [TBL] [Abstract][Full Text] [Related]
6. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2. Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885 [TBL] [Abstract][Full Text] [Related]
7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
8. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2. He J; Wang J; Li S; Li T; Chen K; Zhang S Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2. Hashiguchi Y; Kawano S; Goto Y; Yasuda K; Kaneko N; Sakamoto T; Matsubara R; Jinno T; Maruse Y; Tanaka H; Morioka M; Hattori T; Tanaka S; Kiyoshima T; Nakamura S J Cell Physiol; 2018 Oct; 233(10):6565-6577. PubMed ID: 29150940 [TBL] [Abstract][Full Text] [Related]
11. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells. Ning X; Wang C; Zhang M; Wang K Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374 [TBL] [Abstract][Full Text] [Related]
12. Circ-10720 as a ceRNA adsorbs microRNA-1238 and modulates ZEB2 to boost NSCLC development by activating EMT. Zhang W; Xiao P; Liu B; Zhang Y Eur J Med Res; 2024 Apr; 29(1):226. PubMed ID: 38610009 [TBL] [Abstract][Full Text] [Related]
13. miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2. Li T; Tang C; Huang Z; Yang L; Dai H; Tang B; Xiao B; Li J; Lei X Aging (Albany NY); 2021 Jul; 13(13):17349-17369. PubMed ID: 34226299 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells. Tian Y; Pan Q; Shang Y; Zhu R; Ye J; Liu Y; Zhong X; Li S; He Y; Chen L; Zhao J; Chen W; Peng Z; Wang R J Biol Chem; 2014 Dec; 289(52):36101-15. PubMed ID: 25371200 [TBL] [Abstract][Full Text] [Related]
15. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. You J; Li Y; Fang N; Liu B; Zu L; Chang R; Li X; Zhou Q PLoS One; 2014; 9(3):e91827. PubMed ID: 24626466 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer. Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118 [TBL] [Abstract][Full Text] [Related]
17. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway. Yang S; Li X; Shen W; Hu H; Li C; Han G J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194 [TBL] [Abstract][Full Text] [Related]
20. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]